ArticleFrontiers in oncology2025
FC-YOLO: a fast inference backbone and lightweight attention mechanism-enhanced YOLO for detecting gastric adenocarcinoma in pathological image.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric adenocarcinoma (GAC) is a leading cause of cancer-related mortality, but its histopathological diagnosis is challenged by image complexity and a shortage of pathologists. While deep learning models show promise, many are computationally demanding and lack the fine-grained feature extraction necessary for effective GAC detection. Methods: We propose FC-YOLO, an optimized object detection framework for GAC histopathological image analysis. Based on the YOLOv11s architecture, FC-YOLO incorporates a FasterNet backbone for efficient multi-scale feature extraction, a lightweight Mixed Local-Channel Attention (MLCA) mechanism for feature recalibration, and Content-Aware ReAssembly of FEatures (CARAFE) for enhanced upsampling. The model was evaluated on a public dataset comprising 1,855 images and on a separate, independent clinical dataset consisting of 2,500 pathological images of gastric adenocarcinoma. Results: On the public dataset, FC-YOLO achieved a mean Average Precision (mAP) of 82.8%, outperforming the baseline YOLOv11s by 2.6%, while maintaining a high inference speed of 131.56 FPS. On the independent clinical dataset, the model achieved an mAP of 85.7%, demonstrating strong generalization capabilities. Conclusion: The lightweight and efficient design of FC-YOLO enables superior performance at a low computational cost. It represents a promising tool to assist pathologists by enhancing diagnostic accuracy and efficiency, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.